CDSCO takes away state powers for issuing No Objection Certificate (NOC) for drug’s exports from States

Link copied successfully!

Since 2018, export NOC and manufacturing license were granted by State Licensing Authority for manufacturing unapproved/banned/new drugs solely for export purposes.
However, in recent notification sole licensing authority will be Central Drugs Standard Control Organisation (CDSCO).
- All manufacturers are required to obtain NOC from respective Zonal offices of CDSCO through SUGAM Portal.
- The decision comes in view of Drug Consultative Committee's observation that process of obtaining NOCs from state drug regulators for pharmaceutical products is time-consuming, further delaying export consignment.

About Indian Pharmaceutical Industry (PI)
- Widely recognised as ‘Pharmacy of the World’
- Largest provider of generic medicines globally, occupying a 20% share in global supply by volume.
- Contributes 70% of Diphtheria, Tetanus and Pertussis (DPT) and Bacillus Calmette–Guérin (BCG) vaccines, and 90% of measles vaccines.
- It is expected to reach USD 130 Billion by 2030.

Challenges in Indian Pharmaceutical Industry
- Dependence on China for Active Pharmaceutical Ingredients.
- Instances of contaminated drugs and cough syrups manufactured in India.
- Low investments in Research & Development.

Initiatives taken to strengthen Pharma Industry
- Production Linked Incentive (PLI) scheme for Pharmaceuticals.
- Strengthening of Pharmaceutical Industry Scheme.
- Scheme for Promotion of Bulk Drug Parks.

Ministry: Ministry of Health & Family Welfare.
Headquarter: New Delhi.
- It has 9 Zonal offices.
Performs its regulatory function under Drugs & Cosmetics Act, 1940 and rules 1945.
It is responsible for
- Approval of Drugs, Conduct of Clinical Trials,
- Laying down standards for Drugs,
- Control over quality of imported Drugs, etc.